For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Loss from operations | -55,685 | |||
| Interest income | 5,679 | |||
| Interest expense | -88 | |||
| Other expense | 1,456 | |||
| Foreign exchange gain (loss) | 3,333 | |||
| Total other income | 10,380 | |||
| Income before income taxes | -45,305 | |||
| Income tax (expense) benefit | 235 | |||
| Net loss | -45,540 | |||
| Basic EPS | -1.49 | |||
| Diluted EPS | -1.49 | |||
| Basic Average Shares | 30,487,731 | |||
| Diluted Average Shares | 30,487,731 | |||
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)